Zanzalintinib
id:
zanzalintinib-180-8315128
title:
Zanzalintinib
text:
Zanzalintinib is an oral drug that is undergoing clinical studies. It could potentially be used to treat renal cell carcinoma (RCC). It is being developed by Exelixis. STELLAR-303 is a phase 3, randomized study of zanzalintinib in combination with atezolizumab versus regorafenib in metastatic colorectal cancer. STELLAR-304 (NCT05678673) is a phase 3, randomized study of zanzalintinib in combination with nivolumab versus sunitinib in patients with advanced or metastatic non-clear cell RCC (nccRCC
brand slug:
wiki
category slug:
encyclopedia
description:
Drug currently undergoing clinical studies
original url:
https://en.wikipedia.org/wiki/Zanzalintinib
date created:
2024-01-09T21:21:49Z
date modified:
2024-09-05T12:33:20Z
main entity:
{"identifier":"Q124353001","url":"https://www.wikidata.org/entity/Q124353001"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/aa/Zanzalintinib.svg","width":1145,"height":520}
fields total:
13
integrity:
16